The Respiratory Diseases Drugs Market To Improve Its Performance - PowerPoint PPT Presentation

About This Presentation
Title:

The Respiratory Diseases Drugs Market To Improve Its Performance

Description:

The global respiratory diseases drugs market size is expected to reach $70 billion by 2022, significantly growing at a CAGR of around 6.5% during the forecast period. – PowerPoint PPT presentation

Number of Views:40

less

Transcript and Presenter's Notes

Title: The Respiratory Diseases Drugs Market To Improve Its Performance


1
Respiratory Diseases Drugs Global Market Report
2019
2
Topics Covered
  • Respiratory Diseases Drugs Global Market Size
  • Respiratory Diseases Drugs Global Market Trend
  • Respiratory Diseases Drugs Global Market
    Segmentation

Respiratory Diseases Drugs Global Market Report
2019
3
Introduction-
  • The respiratory diseases drugs market consists of
    sales of respiratory diseases drugs and related
    services by entities (organizations, sole traders
    and partnerships) that produce drugs to treat
    respiratory diseases such as asthma, acute
    bronchitis, emphysema, cystic fibrosis and other
    diseases. This industry includes establishments
    that produce anti-asthmatics and COPD drugs to
    prevent acute attacks caused by respiratory
    diseases and cough and cold preparations to treat
    cough and cold.

Click here to get a sample of this report
4
Companies covered-
  • GlaxoSmithKline Plc,
  • AstraZeneca Plc,
  • Merck Co,
  • Novartis AG,
  • Johnson Johnson.

Click here to get a sample of this report
5
Countries Covered
  • USA
  • China
  • Germany
  • Brazil
  • Japan
  • UK
  • Spain
  • Russia
  • France
  • Australia
  • Italy
  • India
  • Rest of the world

Click here to get a sample of this report
6
Respiratory Diseases Drugs Global
Market Trend
  • The demand for PSE-containing cold, allergy, and
    sinus products is growing due to their
    effectiveness and convenience. PSE is an active
    ingredient found in various cold, allergy, and
    sinus drugs that can provide congestion relief.
    However, PSE-containing medicines are mostly sold
    as a prescription drug, as PSE can also be used
    for the illegal manufacture of methamphetamine, a
    recreational drug. This has led drug
    manufacturers to produce tamper-resistant PSE
    products. For instance, in March 2017,
    pharmaceutical companies Acura Pharmaceuticals
    Inc. and MainPointe Pharmaceuticals LLC entered
    into an agreement, enabling MainPointe
    Pharmaceuticals LLC to market NEXAFED and NEXAFED
    Sinus products in the US and Canada. These drugs
    utilize tamper-resistant PSE formulation to
    prevent the illicit production of methamphetamine.

Click here to get a sample of this report
7
Click here to get a sample of this report
8
Respiratory Diseases Drugs Global
Market Segmentation
  • By type and
  • By geography

Click here to get a sample of this report
9
Critical Data Points
Metrics Indicators
Enterprises Facilities, Employees, Consumption, Expenditure
Customers Segmented By Age, Sex, Behaviour, Attitudes
Economics Data Output, Income
Infrastructure Houses, Roads, Schools And Hospitals
Processes Procedures, Transactions, Contracts
Metrics Indicators
Sales Data Market Sales, Sales By Segment
Market Shares Sales Of Leading Competitors
Units Sold Units/ Volumes/ Weights Sales/ Stock
Imports Exports Import And Export Values And Volumes
Production Data Output, Capacity

 
10
Across 11 Countries and 5 Regions
Russia
Europe
UK
Germany
France
Italy
Spain
Asia
China
USA
Japan
Middle East Africa
India
Americas
Brazil
Oceania
11
Get In Touch
Whatever your need be, at The Business Research
Company we provide research consulting solutions
for businesses, government agencies
consultancies, and market research companies.
12
Related Reports
  • https//www.thebusinessresearchcompany.com/report/
    biologics-global-market-opportunities-and-strategi
    es-to-2021
  • https//www.thebusinessresearchcompany.com/report/
    cardiovascular-drugs-global-market-report
  • https//www.thebusinessresearchcompany.com/report/
    dermatology-drugs-global-market-report

13
Offerings
14
Testimonials
  • "The Business Research Company provides reliable
    and useful information for the technology sector"
  • Janardhan Rajan, Senior Consultant, Tech Mahindra
    (IT Services)
  • An excellent provider. Thorough, timely and with
    outstanding insight delivered in an easily
    digestible format.
  • Paul Thompson, Director, Barclays Bank
  •  
  • The Business Research Company has an ideal
    offering for modern media companies. Whether it
    is finding details of potential customers, doing
    primary interviews, or large scale data
    gathering, its services are ideally suited and
    well priced.
  • Robert Mannix, Insurance Risk Editor, Incisive
    Media
  •  
  • The Business Research Company were very
    responsive and were able to access critical
    business information rapidly as a result of their
    deep knowledge of the (Indian) market. I would
    recommend them wholeheartedly.
  • Lawrence Dore, Partner,  Davidson, Ryan, Dore,
    (Consultancy)

15
Follow us on our social media and message us!
16
Europe The Business Research Company 47
Anchorage Point, 42 Cuba Street, Canary Wharf,
London, England, E14 8NE. 44 207 1930
708 Email info_at_tbrc.info www.tbrc.info
Asia The Business Research Company, Horizon
Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara
Hills Hyderabad (India) 500033 91
8897263534 Email info_at_tbrc.info www.tbrc.info
Americas The Business Research Company 625 South
Avenue, Apt B204, Secane, Philadelphia, PA 19018,
USA 1 3156230293 Email info_at_tbrc.info www.tbrc.
info
Write a Comment
User Comments (0)
About PowerShow.com